International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 4 , Pages 987-992 , 15 March 2008

Postoperative Treatment of Primary Glioblastoma Multiforme With Radiation and Concomitant Temozolomide in Elderly Patients

Received 14 June 2007 ,Revised 27 July 2007 ,Accepted 27 July 2007.

References 

  1. Lowry JK, Snyder JJ, Lowry PW. Brain tumors in the elderly: Recent trends in a Minnesota cohort study. Arch Neurol. 1998;55:922–928
  2. Benson AB, Pregler JP, Bean JA, et al. Oncologists' reluctance to accrue patients onto clinical trials: An Illinois Cancer Center study. J Clin Oncol. 1991;9:2067–2075
  3. Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007;356:1527–1535
  4. Phister JE, Jue SG, Cusack BJ. Problems in the use of anticancer drugs in the elderly. Drugs. 1989;37:551–565
  5. Vuorinen V, Hinkka S, Farkkila M, et al. Debulking or biopsy of malignant glioma in elderly people—a randomised study. Acta Neurochir (Wien). 2003;145:5–10
  6. Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas. J.Neurooncol. 1999;42:227–231
  7. Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 1979;5:1725–1731
  8. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978;49:333–343
  9. Stupp R, Mason WP, Van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996
  10. Combs SE, Gutwein S, Schulz-Ertner D, et al. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. Strahlenther Onkol. 2005;181:372–377
  11. Mirimanoff RO, Gorlia T, Mason W, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol. 2006;24:2563–2569
  12. Brandes A, Fiorentino MV. Treatment of high-grade gliomas in the elderly. Oncology. 1998;55:1–6
  13. Combs SE, Thilmann C, Edler L, et al. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution. J Clin Oncol. 2005;23:8863–8869
  14. Clark TG, Bradburn MJ, Love SB, et al. Survival analysis part I: Basic concepts and first analyses. Br J Cancer. 2003;89:232–238
  15. Clark TG, Bradburn MJ, Love SB, et al. Survival analysis part IV: Further concepts and methods in survival analysis. Br J Cancer. 2003;89:781–786
  16. Curran WJ, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993;85:704–710
  17. Scott CB, Scarantino C, Urtasun R, et al. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: A report using RTOG 90-06. Int J Radiat Oncol Biol Phys. 1998;40:51–55
  18. Barker FG, Chang SM, Larson DA, et al. Age and radiation response in glioblastoma multiforme. Neurosurgery. 2001;49:1288–1297
  19. Kleihues P, Webster K. World Health Organization (WHO) pathology and genetics of tumours of the nervous system. Lyon: International Agency for Research on Cancer; 2000;
  20. Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer. 1987;59:1617–1625
  21. Imperato JP, Paleologos NA, Vick NA. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol. 1990;28:818–822
  22. Netsky MG, August B, Fowler W. The longevity of patients with glioblastoma multiforme. J Neurosurg. 1950;7:261–269
  23. Whittle IR, Basu N, Grant R, et al. Management of patients aged >60 years with malignant glioma: Good clinical status and radiotherapy determine outcome. Br J Neurosurg. 2002;16:343–347
  24. Mohan DS, Suh JH, Phan JL, et al. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys. 1998;42:981–987
  25. Grau JJ, Verger E. Radiotherapy of the brain in elderly patients. Pro:. Eur J Cancer. 2000;36:443–447
  26. Tomita T, Raimondi AJ. Brain tumors in the elderly. JAMA. 1981;246:53–55
  27. Pierga JY, Hoang-Xuan K, Feuvret L, et al. Treatment of malignant gliomas in the elderly. J Neurooncol. 1999;43:187–193
  28. Kelly PJ, Hunt C. The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery. 1994;34:62–66
  29. Whittle IR, Denholm SW, Gregor A. Management of patients aged over 60 years with supratentorial glioma: Lessons from an audit. Surg Neurol. 1991;36:106–111
  30. Meckling S, Dold O, Forsyth PA, et al. Malignant supratentorial glioma in the elderly: Is radiotherapy useful?. Neurology. 1996;47:901–905
  31. Gilbert MR, Bozik M, Armstrong TS, et al. Aggressive chemotherapy treatment of brain tumors in the elderly: Results from a phase II study. Proc Am Soc Clin Oncol. 1996;15:152
  32. Zampieri P, Faggin R, Rigon A, et al. Malignant cerebral gliomas in the elderly. J Neurooncol. 1996;30:155
  33. Stewart LA. Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002;359:1011–1018
  34. DeAngelis LM, Burger PC, Green SB, et al. Malignant glioma: Who benefits from adjuvant chemotherapy?. Ann Neurol. 1998;44:691–695
  35. Brandes AA. State-of-the-art treatment of high-grade brain tumors. Semin Oncol. 2003;30:4–9
  36. Brandes AA, Vastola F, Basso U, et al. A prospective study on glioblastoma in the elderly. Cancer. 2003;97:657–662
  37. Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial. J Clin Oncol. 2004;22:1583–1588
  38. Lutterbach J, Ostertag C. What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma?. J Clin Oncol. 2005;23:2869–2870
  39. Bleehen NM, Stenning SP. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer. 1991;64:769–774

 Conflict of interest: S.E.C. received honoraria from Schering-Plough and served on advisory boards for Schering-Plough. S.E.C., D.S.E., and J.D. received research grants from Schering-Plough.

PII: S0360-3016(07)03865-5

doi: 10.1016/j.ijrobp.2007.07.2368

International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 4 , Pages 987-992 , 15 March 2008

Article Tools

* Image Usage & Resolution